For example, a family-based study among sarcoidosis-affected German families led to the discovery of a mutation in a putative immune regulatory gene, butyrophilin-like 2 (BTNL2), that may explain 23% of the attributable risk in that population [8]. The gene discussed is BTNL2; the disease is sarcoidosis.